|
Adaptive Designs in Clinical Drug Development is one of the finest conferences for the pharmaceutical industry in United Kingdom. The 4th edition of the conference will target on investigating the entire process, from designing to implementation, to explore the potential of adaptive trials now and in the future, for the pharmaceutical industry. It will serve as a magnificent platform, to network with key figures from the adaptive design arena and discuss major issues surrounding designing and carrying out adaptive trials. The 4th Annual Adaptive Designs in Clinical Drug Development Conference 2010 will focus on a wide range of topics, like: Adaptive design regulation in the EU and Japan, Large randomised pivotal trial in cancer, Adaptive trials and traditional designs, Optimal group sequential designs, Dose selection in early phase clinical trials, Adaptive trial designs for oncology trials, Adaptive and non-adaptive strategies for real-time data collection, management and reporting, etc.
Visitor Profile
The targeted visitors at the 4th Annual Adaptive Designs in Clinical Drug Development Conference 2010 are Chief Executives, Vice Presidents, Heads, Directors, Scientists and Project Leaders of:
- Clinical Drug Development
- Trial Design
- Biostatistics
- Regulatory Affairs
- Contract Research Organisations
- Clinical Operations
- Pharmacokinetics
- Pharmacodynamics
- Research and Development
- Intellectual Property
- Legislation & Policy Advice
- Drug and Safety Assessment
- Clinical Pharmacology
- Experimental Medicine
Organizer
SMi Group Ltd